Technical Analysis for BIOVF - Swedish Orphan Biovi

Grade Last Price % Change Price Change
grade C 18.65 -11.19% -2.3500
BIOVF closed down 11.19 percent on Wednesday, August 21, 2019, on 25 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A Down
See historical BIOVF trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New Uptrend Bullish -11.19%
Narrow Range Bar Range Contraction -11.19%
Wide Bands Range Expansion -11.19%
Gapped Up Strength -11.19%
Oversold Stochastic Weakness -11.19%
New Downtrend Bearish -7.01%

Older signals for BIOVF ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. The company offers Elocta to treat haemophilia A; and Alprolix to treat haemophilia B. It also provides Orfadin for the treatment of hereditary tyrosinaemia type 1; and Kineret for the treatment of auto inflammatory condition, as well as Xiapex to treat Dupuytren's contracture and Peyronie's disease. In addition, the company manufactures drug substance for ReFacto AF; and develops BIVV001 and BIVV002 for the treatment of hemophilia. It operates in Sweden, the Middle East, North Africa, Russia, North America, other European countries, and internationally. The company has an agreement with Bioverativ for the development and commercialization of Elocta and Alprolix, as well as XTEN-programs. Swedish Orphan Biovitrum AB (publ) is headquartered in Solna, Sweden.
Biotechnology RTT Medical Specialties Pharmaceuticals Organ Systems Inflammation Hemophilia Haemophilia B Haemophilia Swedish Orphan Biovitrum Treatment Of Hemophilia
Is BIOVF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 0 bearish and 5 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 31.25
52 Week Low 14.2
Average Volume 1,972
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 23.3556
10-Day Moving Average 20.9356
Average True Range 1.7786
ADX 24.36
+DI 47.0573
-DI 52.8764
Chandelier Exit (Long, 3 ATRs ) 25.9142
Chandelier Exit (Short, 3 ATRs ) 23.9858
Upper Bollinger Band 30.4179
Lower Bollinger Band 16.2933
Percent B (%b) 0.17
BandWidth 60.476288
MACD Line -0.0216
MACD Signal Line 0.8062
MACD Histogram -0.8278
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.6500
Resistance 3 (R3) 18.6500 18.6500 18.6500
Resistance 2 (R2) 18.6500 18.6500 18.6500 18.6500
Resistance 1 (R1) 18.6500 18.6500 18.6500 18.6500 18.6500
Pivot Point 18.6500 18.6500 18.6500 18.6500 18.6500
Support 1 (S1) 18.6500 18.6500 18.6500 18.6500 18.6500
Support 2 (S2) 18.6500 18.6500 18.6500 18.6500
Support 3 (S3) 18.6500 18.6500 18.6500
Support 4 (S4) 18.6500